Skip to Content


Active Substance: rimonabant
Common Name: rimonabant
ATC Code: A08AX01
Marketing Authorisation Holder: sanofi-aventis
Active Substance: rimonabant
Status: Withdrawn
Authorisation Date: 2006-06-19
Therapeutic Area: Obesity
Pharmacotherapeutic Group: Antiobesity preparations, excl. diet products

Therapeutic Indication

As an adjunct to diet and exercise for the treatment of obese patients (BMI ≥ 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).

The marketing authorisation for Acomplia has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.